retatrutide phase 3 trials just delivered the most powerful weight loss data ever recorded in a obesity trial. At 104 weeks, participants on the 12 mg dose lost an average of 85 pounds Today, we shared new data

this choice may have helped avoid patients unable to access the drug due to insurance issues after initial order, but did nothing to address the question of people getting access through alternate sources external to our system

Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel J-C, Decker H, Silverman MA, Kazi H, Melo HM, McClean PL, Holscher C, Arnold SE, Talbot K, Klein WL, Munoz DP, Ferreira ST, De Felice FG

From the peptide cost calculator to comprehensive dosing protocols and reconstitution calculators , having the right resources transforms budget management from guesswork into science

The brand notes on its website that most people dont pay the full list price, and while insurance may not cover the full cost, it may cover enough to drive down the price

Because it focuses on insulin sensitivity and liver glucose production, it provides a steady foundation for metabolic stability

It will be interesting to see how the community evolves once its officially released